by admin | Apr 30, 2024 | News & Opinions
By Carleigh Gabryel – UNC Research News – In a new study published in Nature Chemistry, Carolina researcher Ronit Freeman and her colleagues describe the steps they took to manipulate DNA and proteins — essential building blocks of life — to create cells...
by admin | Apr 29, 2024 | News & Opinions
by Heather Landi – Fierce Healthcare – Walgreens is expanding its specialty pharmacy services to offer gene and cell therapy services, supported by a dedicated 18,000-square-foot center in Pittsburgh, the company announced Thursday. The service is part of...
by admin | Apr 24, 2024 | News & Opinions
by Steve Martin – Purdue University – WEST LAFAYETTE, Ind. — Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time...
by admin | Apr 22, 2024 | News & Opinions
By – ISSCR – The international Society for Stem Cell Research will host a free webinar celebrating Earth Day April 22, 2024 Program Description: Celebrate Earth Day by diving into the science of conservation, where the potential of stem cells is harnessed to foster a...
by admin | Apr 19, 2024 | News & Opinions
By CiRA – Kyoto University – In a recent study, Professor Shimpei Gotoh (Department of Clinical Application) and Junior Associate Professor Kazuo Takayama (Department of Cell Growth and Differentiation) teamed up to construct a novel in vitro culture...
by admin | Apr 18, 2024 | News & Opinions
By Aspen Neuroscience SAN DIEGO, April 17, 2024 /PRNewswire/ — Aspen Neuroscience, Inc. announced that the first patient has been dosed in the ASPIRO trial, a Phase 1/2a open label clinical trial to assess safety and tolerability of ANPD001, an autologous,...
